Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Enabling Companies to Produce High-Quality Cannabis-Infused Products
- 80 percent of the company’s total revenue anticipated from the licensing of DehydraTECH™
- Nuke Enterprises renewed its license, sending a strong vote of confidence in the technology
- Enabled GP Holdings to create a high-performing cannabis-infused beverage
- Biolog Inc. is developing products which will allow processors and consumers to turn almost any food or beverage into a cannabis edible
- Beginning production of a line of cannabis-infused alcohol-free beverages through a new licensing agreement
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a drug delivery platform innovator, utilizes its unique patented DehydraTECH™ delivery technology to enhance the products of its clients. This patented delivery mechanism improves the bioabsorption and bioavailability of ingestible substances while also improving taste and smell. For companies entering into or already established in the cannabis industry, this is good news. The bitterness of cannabis when creating consumable products can now be reduced and even eliminated.
Lexaria has licensed DehydraTECH™ to a number of companies that market hemp-based, CBD-infused products. As the only company in the world awarded a patent for the improved delivery of all cannabinoids, Lexaria is strategically positioned to enable and partner with companies to improve high-quality products. Chris Bunka, CEO of LXRP, has indicated that 80 percent or more of the company’s total revenue will come from these licensing deals (http://nnw.fm/c14G1).
A strong vote of confidence came from Nuka Enterprises. After using DehydraTECH™ for nearly two years, Nuka renewed its license with Lexaria. Nuka makes 1906 brand cannabis chocolates. Under the new 10-year semi-exclusive agreement, Nuka will utilize the technology in its U.S.-based products and plans to expand its products and brand to Canada (http://nnw.fm/2eBgF).
This same delivery technology enabled GP Holdings LLC to develop a high performing cannabis beverage with the complete clarity and transparency of sparkling beverages and nearly zero unwanted odors or flavors. GP acquired rights to DehydraTECH™ in a five-year semi-exclusive licensing agreement for beverage applications in California. GP is also working to develop topical skin products with this innovative tech.
Biolog, Inc. entered into an agreement back in February with Lexaria to utilize DehydraTECH™ in a unique line of manufactured dissolvable infusion products. These products will allow processors and consumers to turn almost any food or beverage into a cannabis edible (http://nnw.fm/FaD3P).
The most recent announcement comes from Lexaria and Hill Street Beverage Company Inc. They have signed a definitive agreement to license DehydraTECH™ in the production of a line of cannabis-infused alcohol-free beverages (http://nnw.fm/B06Dd). Hill Street plans to use DehydraTECH™ to create the same award-winning tastes it is known for while providing the consumer with the recreational experience of cannabis, void of any bitter taste. The alcohol-free red and white wines have already undergone lab testing by Lexaria and show virtually zero cannabis taste or odor with the use of DehydraTECH™.
In a news release, Hill Street CEO Terry Donnelly stated, “Our goal is to provide traditional beer and wine drinkers with great tasting products that use cannabis to mimic the onset and duration of effect that has historically come from alcohol, but without alcohol’s toxicity and added calories. While the early versions of our wines infused with Lexaria’s process have shown great promise, we are extremely excited about the progress Lexaria continues to make with their infusion technologies. Lexaria has already demonstrated its importance to our model as a key strategic partner in our business, and this agreement secures our future together. As Hill Street’s progress into producing the world’s finest alcohol-free and cannabis-infused beverages continues, Lexaria has demonstrated that they will continue to innovate and improve on their process. This will help to ensure Hill Street is always at the forefront of producing world-class wine, beer and other adult format beverages.”
Lexaria is expected to sign 6-12 more licensing agreements in 2018 through its four wholly owned subsidiaries serving the nicotine, hemp, pharmaceutical and cannabis industries.
For more information, visit the company’s website at www.LexariaBioscience.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- 80 percent of the company’s total revenue anticipated from the licensing of DehydraTECH™
- Nuke Enterprises renewed its license, sending a strong vote of confidence in the technology
- Enabled GP Holdings to create a high-performing cannabis-infused beverage
- Biolog Inc. is developing products which will allow processors and consumers to turn almost any food or beverage into a cannabis edible
- Beginning production of a line of cannabis-infused alcohol-free beverages through a new licensing agreement
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a drug delivery platform innovator, utilizes its unique patented DehydraTECH™ delivery technology to enhance the products of its clients. This patented delivery mechanism improves the bioabsorption and bioavailability of ingestible substances while also improving taste and smell. For companies entering into or already established in the cannabis industry, this is good news. The bitterness of cannabis when creating consumable products can now be reduced and even eliminated.
Lexaria has licensed DehydraTECH™ to a number of companies that market hemp-based, CBD-infused products. As the only company in the world awarded a patent for the improved delivery of all cannabinoids, Lexaria is strategically positioned to enable and partner with companies to improve high-quality products. Chris Bunka, CEO of LXRP, has indicated that 80 percent or more of the company’s total revenue will come from these licensing deals (http://nnw.fm/c14G1).
A strong vote of confidence came from Nuka Enterprises. After using DehydraTECH™ for nearly two years, Nuka renewed its license with Lexaria. Nuka makes 1906 brand cannabis chocolates. Under the new 10-year semi-exclusive agreement, Nuka will utilize the technology in its U.S.-based products and plans to expand its products and brand to Canada (http://nnw.fm/2eBgF).
This same delivery technology enabled GP Holdings LLC to develop a high performing cannabis beverage with the complete clarity and transparency of sparkling beverages and nearly zero unwanted odors or flavors. GP acquired rights to DehydraTECH™ in a five-year semi-exclusive licensing agreement for beverage applications in California. GP is also working to develop topical skin products with this innovative tech.
Biolog, Inc. entered into an agreement back in February with Lexaria to utilize DehydraTECH™ in a unique line of manufactured dissolvable infusion products. These products will allow processors and consumers to turn almost any food or beverage into a cannabis edible (http://nnw.fm/FaD3P).
The most recent announcement comes from Lexaria and Hill Street Beverage Company Inc. They have signed a definitive agreement to license DehydraTECH™ in the production of a line of cannabis-infused alcohol-free beverages (http://nnw.fm/B06Dd). Hill Street plans to use DehydraTECH™ to create the same award-winning tastes it is known for while providing the consumer with the recreational experience of cannabis, void of any bitter taste. The alcohol-free red and white wines have already undergone lab testing by Lexaria and show virtually zero cannabis taste or odor with the use of DehydraTECH™.
In a news release, Hill Street CEO Terry Donnelly stated, “Our goal is to provide traditional beer and wine drinkers with great tasting products that use cannabis to mimic the onset and duration of effect that has historically come from alcohol, but without alcohol’s toxicity and added calories. While the early versions of our wines infused with Lexaria’s process have shown great promise, we are extremely excited about the progress Lexaria continues to make with their infusion technologies. Lexaria has already demonstrated its importance to our model as a key strategic partner in our business, and this agreement secures our future together. As Hill Street’s progress into producing the world’s finest alcohol-free and cannabis-infused beverages continues, Lexaria has demonstrated that they will continue to innovate and improve on their process. This will help to ensure Hill Street is always at the forefront of producing world-class wine, beer and other adult format beverages.”
Lexaria is expected to sign 6-12 more licensing agreements in 2018 through its four wholly owned subsidiaries serving the nicotine, hemp, pharmaceutical and cannabis industries.
For more information, visit the company’s website at www.LexariaBioscience.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
